Milan Laboratories (India) Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 2003.
2003 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Milan Laboratories (India) Private Limited

Milan Laboratories (India) Private Limited, a active private limited company, was established on 26 March 2003 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2003PTC139736. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.98 Cr.

It upholds a compliant status. Employing 628 professional, Its leadership includes Upendra Madan Despande (Director), Rohini Rajeev Dongre (Director), Sharwari Upendra Deshpande (Director). Past directors included Upendra Madan Despande, Rahul Rajeev Dongre. It holds ₹70.39 Cr open charges and ₹79.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 303/304, 3Rd Floor, Odyssey It Park Wagle Estate, Midc, Thane(W), Thane, Maharashtra, 400604.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2003PTC139736

  • Registration Number

    139736

  • Incorporation Date

    26 March 2003

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.98 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.98 Cr
  • Company Age 23 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 70.39 Cr
  • Satisfied Charges ₹ 79.75 Cr
  • Revenue Growth **** 42.40%
  • Profit Growth **** 24.85%
  • Ebitda **** 57.55%
  • Net Worth 22.88%
  • Total Assets **** 18.21%
Company report

Milan Laboratories (India) Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Milan Laboratories (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Milan Laboratories (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Upendra Madan Despande Director 26 Mar 2003 Current
Rohini Rajeev Dongre Director 26 Mar 2003 Current
Sharwari Upendra Deshpande Director 13 Mar 2025 Current
Rahul Rajeev Dongre Director 23 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Mar 2025 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Milan Laboratories (India).

Milan Laboratories (India) Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 42.4% increase. The company also saw a substantial improvement in profitability, with a 24.85% increase in profit. The company's net worth Soared by an impressive increase of 22.88%.

Milan Laboratories (India) revenue growth over time
Milan Laboratories (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 42.40%
*******
*******
*******
*******
Revenue from Operations
*******
 43.84%
*******
*******
*******
*******
Total Assets
*******
 18.21%
*******
*******
*******
*******
Profit or Loss
*******
 24.85%
*******
*******
*******
*******
Net Worth
*******
 22.88%
*******
*******
*******
*******
EBITDA
*******
 57.55%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Milan Laboratories (India)?

In 2024, Milan Laboratories (India) had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹703,870,000.00

Satisfied Charges

₹797,510,000.00

Charges Breakdown by Lending Institutions
  • Others : 52.20 Cr
  • Standard Chartered Bank : 16.00 Cr
  • Dbs Bank Ltd : 1.65 Cr
  • Tata Capital Financial Services Limited : 0.54 Cr
Latest Charge Details
Date Lender Amount Status
31 Jan 2024 Standard Chartered Bank ₹10.00 Cr Open
11 Apr 2022 Others ₹20.00 Cr Open
02 Jan 2021 Standard Chartered Bank ₹1.00 Cr Open
02 Jan 2021 Standard Chartered Bank ₹5.00 Cr Open
18 Sep 2019 Others ₹12.20 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Milan Laboratories (India)?

Milan Laboratories (India) has a workforce of 576 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Milan Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Milan Laboratories (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Milan Laboratories (India)
Recent Activity within the Organization
  • Charges

    A charge registered on 01 Apr 2011 via Charge ID 10285507 with Tata Capital Limited was fully satisfied on 08 Sep 2025. was recorded as a recent event.

  • Director Appointment

    Progress on Rahul Rajeev Dongre was appointed as a Director was appointed as a Director on 23 May 2025 & has been associated with this company since 1 year 2 days . was documented.

  • Director Appointment

    The activity Sharwari Upendra Deshpande was appointed as a Director was appointed as a Director on 13 Mar 2025 & has been associated with this company since 1 year 2 months . was completed.

  • Charges

    Progress on A charge registered on 25 Jan 2022 via Charge ID 100542691 with Others was fully satisfied on 17 Feb 2025. was documented.

  • Charges

    A charge registered on 08 Sep 2021 via Charge ID 100478192 with Standard Chartered Bank was fully satisfied on 17 Feb 2025. was recorded as a recent event.

  • Annual General Meeting

    Milan Laboratories (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Milan Laboratories (India) Private Limited?

The CIN of Milan Laboratories (India) Private Limited is U24230MH2003PTC139736.

Where is Milan Laboratories (India) Private Limited headquartered?

Milan Laboratories (India) Private Limited is headquartered at 303/304, 3Rd Floor, Odyssey It Park Wagle Estate, Midc, Thane(W), Thane, Maharashtra, 400604.

When was Milan Laboratories (India) Private Limited incorporated?

Milan Laboratories (India) Private Limited was incorporated on 26 March 2003.

Who are the current directors of Milan Laboratories (India) Private Limited?

The current directors of Milan Laboratories (India) Private Limited are

What is the primary industry of Milan Laboratories (India) Private Limited?

The primary industry of Milan Laboratories (India) Private Limited is Manufacturing.

Is Milan Laboratories (India) Private Limited a listed company?

Milan Laboratories (India) Private Limited is unlisted.

What is the capital structure of Milan Laboratories (India) Private Limited?

The authorized capital of Milan Laboratories (India) Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.98 Cr.

What is the compliance status of Milan Laboratories (India) Private Limited?

The compliance status of Milan Laboratories (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available